All articles by Allie Nawrat

1. RedHill’s opaganib authorised for compassionate use in Italy

   Gastrointestinal disease-focused US-Israeli biopharma company RedHill has received authorisation from the Italian National Institute for Infectious Diseases and Central Italian…
   Read More…

   6 Apr
2. GSK and Vir collaborate on Covid-19 drug and vaccine R&D

   GlaxoSmithKline (GSK) and infectious disease specialists Vir Biotechnology have signed an agreement to collaborate on researching and developing drugs and…
   Read More…

   6 Apr
3. Coronavirus company news summary

   6 April 2020  Researchers from the Biomedicine Discovery Institute (BDI) at Monash University,  Australia, have found that an anti-parasitic drug…
   Read More…

   6 Apr
4. Clinova studies rehydration product’s ability to speed up recovery from Covid-19

   UK-based consumer health company Clinova initiates a UK study into the effectiveness of its oral rehydration solution (ORS) in Covid-19…
   Read More…

   6 Apr
5. Novartis and Incyte to trial Jakavi for Covid-19

   Novartis, in alliance with Incyte, has announced plans to evaluate Jakavi (ruxolitinib) in a Phase III clinical trial to treat…
   Read More…

   3 Apr
6. ImmunityBio and Microsoft create 3D model to support Covid-19 research

   Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s…
   Read More…

   2 Apr
7. Gates Foundation’s Covid-19 accelerator makes first investments

   The Bill & Melinda Gates Foundation, Wellcome and Mastercard’s Covid-19 Therapeutics Accelerator, which was launched in mid-March with $125m, has…
   Read More…

   2 Apr
8. ImmunityBio and Microsoft create 3D model to support Covid-19 research

   Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s…
   Read More…

   2 Apr
9. Exscientia forms UK-US partnership to screen possible Covid-19 drugs

   AI drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond Light…
   Read More…

   1 Apr
10. Exscientia forms UK-US partnership to screen possible Covid-19 drugs

    Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond…
    Read More…

    1 Apr